CME/CE Courses New

Featured Courses

The Emerging Role of CGRP Inhibitors in the Prevention and Treatment of Migraine

The emergence of four monoclonal antibodies or therapies targeting calcitonin gene-related peptide (CGRP) has transformed the treatment of migraine. This presentation reviews the discovery of this drug class, analyzes data from clinical trials, discusses future therapies in the class, and highlights clinical pearls to help attendees better understand these therapies and integrate them into clinical practice.

Bridging the Gap in the Diagnosis and Management of Postmenopausal Osteoporosis

New guidelines that incorporate all the available treatment options for postmenopausal osteoporosis have been recently published, however, diagnosis and treatment gaps may persist, as questions remain about the risk assessment, diagnostic interpretation, as well as therapy selection, monitoring, and appropriate switching or tapering off.

Implementing a Shingles Protocol in Primary Care | myCME

The first episode of this CMEOCast podcast series focuses on developing best practices to implement a shingles protocol in primary care settings.

Practice Pearls on Managing Influenza in the Here and Now | myCME

In this continuing education activity, expert clinicians discuss optimal ways to diagnose and treat influenza during the COVID-19 pandemic.

Improving the Treatment of Severe Asthma in the Biologics Age: An Interdisciplinary Approach to Optimal Patient Outcomes | myCME

This Journal Club series provides expert perspectives to translate science into practice for improving the quality of life of pediatric patients with asthma.

Keep an Eye Out: Diagnosis and Management of Dry Eye Disease | myCME

Dry eye disease management is challenging due to its complex pathogenesis and heterogenous clinical presentation. Clinicians should review the 2019 American Academy of Ophthalmology recommendations for the management of dry eye, which stratify patients by disease severity and suggest a stepwise approach to treatment. Additionally, an understanding of the agents available including their MOA, and efficacy/safety data is needed in order to treat dry eye according to etiology and not just severity.

Making the Case for Pharmacologic Treatment in Alcohol Use Disorder | myCME

Alcohol use disorder (AUD) is a chronic disorder that occurs along a spectrum of mild, moderate, and severe disease. Three agents indicated for AUD, as well as several off-label medications, can help patients achieve better overall health outcomes by reducing their alcohol intake.

Approaching the Contemplative Patient with Alcohol Use Disorder | myCME

Alcohol use disorder (AUD) is a significant public health issue in the United States, responsible for 88,000 deaths and costs of $223.5 billion annually. Despite the gravity of this disorder, many with AUD do not think their drinking is a serious problem. Addiction experts discuss messages that resonate with individuals who do not see their drinking as a problem, the myth of needing to “hit bottom” before seeking treatment, and strategies for managing patients with AUD.

The Neurobiology of Alcohol Use Disorder and Treatment | myCME

Alcohol use disorder (AUD) is now considered a chronic but treatable disease. Two addiction medicine experts discuss the importance of individualizing treatment strategies for AUD.

Case Study: Initiating AUD Treatment for a 49-Year-Old Woman Referred After an ED Visit | myCME

Outpatient management for alcohol use disorder (AUD) can be a formidable challenge, especially in a patient who is resistant to treatment. Clinicians need to recognize multiple issues, including concerns about comorbidities and drug-drug interactions, when initiating treatment in patients recently referred from the emergency department.

Breast Implant Illness: What’s the Evidence? | myCME

In the past few years, clinicians have reported on a phenomenon known as breast implant illness (BII), a wide variety of systemic symptoms—including fatigue, brain fog, joint pain, headache, hair loss, anxiety, and depression—that they believe are related to their breast implants.

Unmet Needs and the Evolving Landscape in Acute Treatment of Migraine: Primary Care Professionals on the Front Line | myCME

Novel targeted therapies for the acute treatment of migraine—5-HT1F and CGRP receptor agonists—lack the CV contraindications of older migraine medications.